SPL 1.08% 9.4¢ starpharma holdings limited

Ann: App 4E/Annual Report to shareholders, page-38

  1. 9,234 Posts.
    lightbulb Created with Sketch. 823

    "
    well,FRE has 2.2 million cash in bank

    and a 30 mill market cap

    spl has 35 odd million cash

    for a 59 mill market cap..why are shareholders notmarching infront of SPL H>Q??? "

    Different companies at different stages. One simple one complicated . One good communication IMO one harder to understand.....with totally different shareholder expectations. One carrying large expensed - one carrying small expenses.

    Thoughts regarding FRE - Have a binary event about to happen. Will add value that they can raise against or crap themselves . Suporters and dir have deep pockets either way is my theory. Even good trials can fail or have data issues so never a guarantee but wait for readout.
    FRE have small outgoings - options to partner upon sucess or fund approvals and rollout with IMO core expensive work already done inclusive of having a manufacturer. Distributer agreement upon a trial sucess or upon c*ry approval will fund . Short term limited funding probably avaliable via directors again - why not they are confident and like the extra exposure IMO and don't want to see costs of public issue and sharks involved.
    Would be fair to existing holders to include a low priced option in any funding they were involved in and also add as a great TO barrier as a increased hurdle . Exercise of option or convertibles could fund as required . $2.2 mill will get em past next hurdle is the simple explaination and hopefully be enough to stop a massive dillution event.


    SPL - welll they have large ongoing expenses and large obligations witha expensive structure. $ even after costs saving measures are still going out fast. Internal development needs restart to get new indications to a stage wher ethey can be partnered IMO .

    In regards to share price on market - there is little logic in short term as always undervalued or overvalued however it does indicate the IMO dissatisification with communication IMO with regards tp SPL. Always a convoluted complicated message - such is cancer and trials when run by partners. Much of teh confusion IMO added to by posters promoting only certain positive aspects on forums so expectations on timing are too great. Company timings have also been out and ammended as well- some valid and understandable - others are WTF due to information supplied.? . FRE is a simple 1 trick pony initially, trial, approve , lodge applications approve manufacture distribute sell , binary at several points so pretty easy to communicate and fresh from prospectus so no murky history




 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $829 8.824K

Buyers (Bids)

No. Vol. Price($)
1 249999 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 50000 1
View Market Depth
Last trade - 12.01pm 08/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.